Equities

Jiang Zhong Pharmaceutical Co Ltd

600750:SHH

Jiang Zhong Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)18.40
  • Today's Change-2.87 / -13.49%
  • Shares traded7.78m
  • 1 Year change-13.53%
  • Beta0.7479
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Jiang Zhong Pharmaceutical Co Ltd grew revenues 13.00% from 3.89bn to 4.39bn while net income improved 18.40% from 598.24m to 708.29m.
Gross margin63.72%
Net profit margin19.56%
Operating margin23.08%
Return on assets13.36%
Return on equity19.31%
Return on investment20.72%
More ▼

Cash flow in CNYView more

In 2023, Jiang Zhong Pharmaceutical Co Ltd increased its cash reserves by 16.68%, or 91.82m. The company earned 1.04bn from its operations for a Cash Flow Margin of 23.60%. In addition the company used 127.03m on investing activities and also paid 817.05m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share5.91
Tangible book value per share5.22
More ▼

Balance sheet in CNYView more

Jiang Zhong Pharmaceutical Co Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 0.04%.
Current ratio1.13
Quick ratio0.8833
Total debt/total equity0.0005
Total debt/total capital0.0004
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 13.04% and 17.89%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)5.42%
Div growth rate (5 year)40.99%
Payout ratio (TTM)108.64%
EPS growth(5 years)8.45
EPS (TTM) vs
TTM 1 year ago
9.93
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.